Thyroid cancer trials in Italy

In Italy 22 Also abroad 226

22 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 11 November 2026. Ask the study team whether a trial fits you.

No phaseTaking people
Definition of Mutational Profile of Papillary Thyroid Tumors by Mass-ARRAY
Where
Milan
People
600
Run by
Istituto Auxologico Italiano
See details and how to joinNCT05766098
Phase 1/2Taking people
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
Where
Milan, Rome, Rozzano
Age
18 years and over
People
554 worldwide
Run by
Institut de Recherches Internationales Servier
See details and how to joinNCT05786924 · EU 2025-523474-16-00
No phaseTaking people
Cross Immune Response Between Breast Carcinoma and Thyroid Autoimmunity: Impact on Prognosis and Treatment
Where
Milan
Age
18 years to 80 years
People
496
Run by
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
See details and how to joinNCT07870148
Phase 1Taking people
Phase I Study of [225Ac]Ac-ETN029 in Patients With Advanced DLL3-expressing Solid Tumors
Where
Milan, Naples
Age
18 years to 100 years
People
116 worldwide
Run by
Novartis Pharmaceuticals
See details and how to joinNCT07006727 · EU 2024-519111-34-00
Phase 2Taking people
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
Where
Meldola, Milan, Naples
Age
8 years and over
People
254 worldwide
Run by
Fore Biotherapeutics
See details and how to joinNCT05503797 · EU 2024-513578-23-00
Phase 4Not yet taking people in Italy
Prospective, multicenter, randomized study on combined LT4 + LT3 therapy versus LT4 in the control of TSH in patients with advanced thyroid cancer treated with tyrosine kinase inhibitors.
Where
Catania, Milan, Naples, Padova, Pavia, Perugia, Pisa, Rome, Salerno, Siena
Age
18 years and over
People
110
Run by
Ceinge Biotecnologie Avanzate Franco Salvatore S.c.a.r.l.
See details and how to join2026-526113-28-00 · EU 2026-526113-28-00
Phase 1/2Taking people
A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
Where
Aviano, Milan, Rome
Age
12 years and over
People
500 worldwide
Run by
Turning Point Therapeutics, Inc.
See details and how to joinNCT03093116 · EU 2024-512606-25-00
Phase 2Taking people
Pembrolizumab in High-risk Thyroid Cancer
Where
Milan, Pavia, Rome
Age
18 years to 64 years
People
25
Run by
Istituti Clinici Scientifici Maugeri SpA
See details and how to joinNCT05852223 · EU 2024-519129-38-00
No phaseTaking people
Thyroid Carcinoma in Cancer Patients Undergoing Radiotherapy
Where
Bologna
Age
10 years to 43 years
People
2,550
Run by
IRCCS Azienda Ospedaliero-Universitaria di Bologna
See details and how to joinNCT07473518
No phaseTaking people
EMDR Integrative Group Protocol and Individual Treatment for Patients With Cancer: A Pilot Study
Where
Milan
Age
18 years to 100 years
People
25
Run by
Università Cattolica di Milano
See details and how to joinNCT07447089
No phaseTaking people
Impact of Conventional Treatments and Clinical Variables on Thyroid Cancer
Where
Milan
People
3,000
Run by
Istituto Auxologico Italiano
See details and how to joinNCT05752604
No phaseTaking people
An International Study on Pediatric Patients With Rare Tumors.
Where
Padova
Age
0 years to 18 years
People
6,250
Run by
Azienda Ospedaliera di Padova
See details and how to joinNCT07072143
No phaseEnrolling by invitation
Observational Study on Thyroid Tumors and EvaLuation of the roLe of New pOntential Predictive/Prognostic Factors
Where
Roma
Age
18 years and over
People
100
Run by
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
See details and how to joinNCT07064369
Phase 2Taking people
APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors
Where
Ancona, Bologna, Meldola, Milan, Padova, Turin
Age
18 years and over
People
497 worldwide
Run by
Apollomics Inc.
See details and how to joinNCT03175224 · EU 2024-514542-37-00
No phaseTaking people
Observational Study Analysing the Transcriptome and Mutational Status of Thyroid Carcinomas of Follicular Origin with Different Degrees of Malignancy
Where
Naples
Age
18 years and over
People
80
Run by
IRCCS SYNLAB SDN
See details and how to joinNCT06878534
No phaseTaking people
Evaluation of the Clinical Utility of Circulating Biomarkers in Advanced Thyroid Carcinomas
Where
Bologna
Age
18 years and over
People
10
Run by
IRCCS Azienda Ospedaliero-Universitaria di Bologna
See details and how to joinNCT06863805
No phaseEnrolling by invitation
PET-TC in Thyroid Evaluation
Where
Bologna
Age
18 years and over
People
418
Run by
IRCCS Azienda Ospedaliero-Universitaria di Bologna
See details and how to joinNCT06852144
No phaseTaking people
Evaluation of Different Diagnostic Therapeutic Strategies in Patients with Thyroid Pathology
Where
Bologna
Age
18 years and over
People
5,850
Run by
IRCCS Azienda Ospedaliero-Universitaria di Bologna
See details and how to joinNCT06779747
No phaseTaking people
The Unmet Needs of Cancer Survivors in Ausl IRCCS Reggio Emilia
Where
Reggio Emilia
Age
18 years and over
People
45
Run by
University of Modena and Reggio Emilia
See details and how to joinNCT06236373
No phaseTaking people
Minimally Invasive Treatments of the Thyroid
Where
Milan
Age
18 years and over
People
270
Run by
European Institute of Oncology
See details and how to joinNCT06333587
Phase 3Taking people
TSH Suppression During Radiotherapy on Thyroid Site to Prevent Iatrogenic Hypothyroidism in Pediatric Cancer Patients
Where
Milan
People
68
Run by
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
See details and how to joinNCT05316922
No phaseNot yet taking people in Italy
Assessment the Cancer Risk of Indeterminate Thyroid Nodules Through Integration of Clinical, Ultrasonographic and Multiomic Features
Where
Cagliari
Age
18 years and over
People
256
Run by
University of Cagliari
See details and how to joinNCT05428371